Log in

SILVAPHL Silva Pharmaceuticals Ltd. DSEBD · Bangladesh

Silva Pharmaceuticals (SILVAPHL) news

Silva Pharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker SILVAPHL, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Silva Pharmaceuticals news

We have not published a story on Silva Pharmaceuticals yet. When there is news, it will appear here.

Questions about Silva Pharmaceuticals

What is the ticker symbol of Silva Pharmaceuticals?

Silva Pharmaceuticals Ltd. trades under the ticker SILVAPHL on DSEBD.

Where is Silva Pharmaceuticals listed?

Silva Pharmaceuticals Ltd. is listed on DSEBD.

Which country or territory is Silva Pharmaceuticals listed under?

Our directory records Silva Pharmaceuticals Ltd. under Bangladesh.

What does Silva Pharmaceuticals do?

Our directory classifies Silva Pharmaceuticals Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Silva Pharmaceuticals?

The ISIN recorded for Silva Pharmaceuticals Ltd. is BD0493SPL001.

Does aibio.space cover Silva Pharmaceuticals?

aibio.space lists Silva Pharmaceuticals Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Silva Pharmaceuticals?

Companies in our directory listed in the same country and business area as Silva Pharmaceuticals: Advent Pharma, Beximco Pharmaceuticals Plc, BN SINA Pharmaceutical Industry, Ambee Pharmaceuticals, Unilever Consumer Care, Silco Pharmaceuticals.

Investor discussion: Silva Pharmaceuticals

Members talk about Silva Pharmaceuticals (SILVAPHL). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Listing details

Silva Pharmaceuticals Ltd. is a public biotech or pharmaceutical company listed on DSEBD under the ticker SILVAPHL, recorded under Bangladesh. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Silva Pharmaceuticals Ltd.
Ticker
SILVAPHL
Listing
DSEBD
Country or territory
Bangladesh
Business scope
Pharmaceuticals: Major
ISIN
BD0493SPL001
Last quote in directory
2026-10-19
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.